BioNTech to Host AI Day as an Edition of its Innovation Series on October 1, 2024
BioNTech SE (Nasdaq: BNTX) and its AI company InstaDeep are set to host an AI Day as part of BioNTech's Innovation Series on October 1, 2024, in London. The event, starting at 09:00 a.m. EDT (3:00 p.m. CEST), will showcase the companies' AI strategy, capabilities, and its application in BioNTech's pipeline and internal processes.
A live webcast will be available for viewers, with a replay accessible on BioNTech's website for one year following the event. This presentation aims to provide insights into how BioNTech is leveraging AI technologies to advance its biopharmaceutical research and development efforts.
BioNTech SE (Nasdaq: BNTX) e la sua azienda di intelligenza artificiale InstaDeep organizzeranno un AI Day come parte della Serie di Innovazione di BioNTech il 1 ottobre 2024, a Londra. L'evento, che avrà inizio alle 09:00 a.m. EDT (3:00 p.m. CEST), presenterà la strategia, le capacità e l'applicazione dell'intelligenza artificiale nelle pipeline e nei processi interni di BioNTech.
Una diretta streaming sarà disponibile per gli spettatori, con una registrazione accessibile sul sito web di BioNTech per un anno dopo l'evento. Questa presentazione ha l'obiettivo di fornire approfondimenti su come BioNTech stia sfruttando le tecnologie AI per promuovere i propri sforzi di ricerca e sviluppo biopharmaceuticali.
BioNTech SE (Nasdaq: BNTX) y su empresa de inteligencia artificial InstaDeep llevarán a cabo un Día de IA como parte de la Serie de Innovación de BioNTech el 1 de octubre de 2024, en Londres. El evento, que comenzará a las 09:00 a.m. EDT (3:00 p.m. CEST), mostrará la estrategia de IA de las empresas, sus capacidades y su aplicación en la línea de productos y en los procesos internos de BioNTech.
Se ofrecerá una transmisión en vivo para los espectadores, con una repetición accesible en el sitio web de BioNTech durante un año tras el evento. Esta presentación tiene como objetivo proporcionar información sobre cómo BioNTech está aprovechando las tecnologías de IA para avanzar en sus esfuerzos de investigación y desarrollo biofarmacéutico.
BioNTech SE (Nasdaq: BNTX)와 인공지능 회사 InstaDeep가 AI Day를 개최할 예정입니다. 이는 BioNTech의 혁신 시리즈의 일환으로, 2024년 10월 1일 런던에서 열립니다. 행사 시작은 09:00 a.m. EDT (3:00 p.m. CEST)이며, 두 회사의 인공지능 전략, 역량 및 BioNTech의 파이프라인과 내부 프로세스에의 적용을 소개할 예정입니다.
라이브 웹캐스트가 시청자에게 제공되며, 이벤트 후 1년 동안 BioNTech 웹사이트에서 재생 가능합니다. 이 발표는 BioNTech가 생물제약 연구 및 개발 노력을 어떻게 인공지능 기술을 활용하고 있는지에 대한 통찰력을 제공하는 것을 목표로 합니다.
BioNTech SE (Nasdaq: BNTX) et sa société d'intelligence artificielle InstaDeep organiseront un AI Day dans le cadre de la série d'innovation de BioNTech le 1er octobre 2024 à Londres. L'événement, qui débutera à 09:00 a.m. EDT (3:00 p.m. CEST), mettra en avant la stratégie, les capacités et l'application de l'intelligence artificielle dans le pipeline et les processus internes de BioNTech.
Une diffusion en direct sera disponible pour les spectateurs, avec une rediffusion accessible sur le site web de BioNTech pendant un an après l'événement. Cette présentation vise à fournir des informations sur la manière dont BioNTech utilise les technologies d'IA pour faire avancer ses efforts de recherche et développement biopharmaceutiques.
BioNTech SE (Nasdaq: BNTX) und ihr KI-Unternehmen InstaDeep werden am 1. Oktober 2024 in London einen AI Day als Teil der Innovationsreihe von BioNTech veranstalten. Die Veranstaltung beginnt um 09:00 a.m. EDT (3:00 p.m. CEST) und wird die KI-Strategie, -fähigkeiten und deren Anwendung in BioNTechs Pipeline sowie internen Prozessen präsentieren.
Ein Live-Stream wird für die Zuschauer verfügbar sein, mit einer Wiedergabe, die ein Jahr nach der Veranstaltung auf der BioNTech-Website zugänglich ist. Diese Präsentation zielt darauf ab, Einblicke zu geben, wie BioNTech KI-Technologien nutzt, um seine biopharmazeutischen Forschungs- und Entwicklungsbemühungen voranzutreiben.
- BioNTech is demonstrating commitment to AI integration in its operations
- The event showcases BioNTech's innovation and technological advancements
- Potential for increased investor interest due to focus on AI applications in biotech
- None.
MAINZ, Germany, September 17, 2024 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech”), alongside its artificial intelligence (“AI”) company InstaDeep Ltd. (“InstaDeep”), will host an AI Day, an edition of BioNTech’s “Innovation Series”, at 09:00 a.m. EDT (3:00 p.m. CEST) on Tuesday, October 1st, 2024 in London, United Kingdom. The event will provide an overview of BioNTech’s and InstaDeep’s AI strategy and capabilities, and the application of AI in BioNTech’s pipeline and internal processes.
The live webcast of the event will be available via this link.
A replay of the webcast will be available shortly after the event’s conclusion and archived on BioNTech’s website for one year after.
About BioNTech
Biopharmaceutical New Technologies (BioNTech) is a global next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. BioNTech exploits a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals. Its broad portfolio of oncology product candidates includes individualized and off-the-shelf mRNA-based therapies, innovative chimeric antigen receptor (CAR) T cells, several protein-based therapeutics, including bispecific immune checkpoint modulators, targeted cancer antibodies and antibody-drug conjugate (ADC) therapeutics, as well as small molecules. Based on its deep expertise in mRNA vaccine development and in-house manufacturing capabilities, BioNTech and its collaborators are developing multiple mRNA vaccine candidates for a range of infectious diseases alongside its diverse oncology pipeline. BioNTech has established a broad set of relationships with multiple global and specialized pharmaceutical collaborators, including Biotheus, DualityBio, Fosun Pharma, Genentech, a member of the Roche Group, Genevant, Genmab, MediLink, OncoC4, Pfizer and Regeneron.
For more information, please visit www.BioNTech.com.
CONTACTS
Media Relations
Jasmina Alatovic
+49 (0) 6131 9084 1513
Media@biontech.de
Investor Relations
Victoria Meissner, M.D.
Investors@biontech.de
FAQ
When is BioNTech (BNTX) hosting its AI Day event?
What will be discussed at BioNTech's (BNTX) AI Day event?
How can investors access BioNTech's (BNTX) AI Day presentation?
What is the significance of BioNTech's (BNTX) AI Day for investors?
